Variables | Category | Treatment outcome | COR(95%CI) | AOR(95%CI) | P-value | |
---|---|---|---|---|---|---|
Good | Poor | |||||
Age | < 2 months | 11(8.33%) | 5(7.81%) | 1 | 0.44(0.12–1.63) | 0.22 |
> = 2 months | 121(91.67%) | 59(92.19%) | 0.93(0.31–2.81) | 1 | ||
Sex | Male | 73(55.30%) | 39(60.94%) | 0.79(0.43–1.46) | 0.77(0.38–1.54) | 0.46 |
Female | 59(44.70%) | 25(39.06%) | 1 | 1 | ||
Residency | Urban | 73(55.30%) | 29(45.31%) | 1 | 1 | 0.072 |
Rural | 59(44.70%) | 35(54.69%) | 0.67(0.37–1.22) | 0.52(0.26–1.06) | ||
Duration of illness | < 72 h | 58(43.94%) | 34(53.13%) | 1 | 1 | 0.066 |
> = 72 h | 74(56.06%) | 30(46.87%) | 1.45(0.79–2.63) | 1.92(0.96–3.84) | ||
Oxygen use | Yes | 15 (11.36%) | 19(29.69%) | 1 | 1 | 0.008 |
No | 117(88.64%) | 45(70.31%) | 3.29(1.54–7.04) | 3.12(1.34–7.25) | ||
Immunization history | Complete | 67(50.76%) | 34(53.13%) | 1 | 1 | 0.63 |
Incomplete | 65(49.24%) | 30(46.87%) | 1.10(0.61–1.99) | 1.19(0.59–2.38) | ||
Corticosteroid used for meningitis treatment | Yes | 69(52.27%) | 46(71.86%) | 1 | 1 | 0.017 |
No | 63(47.73%) | 18(28.14%) | 1.50(1.23–4.44) | 2.37(1.17–4.81) | ||
Co-morbidity | No | 97(73.48%) | 29(45.31%) | 1 | 1 | < 0.001 |
Yes | 35(26.52%) | 35(54.69%) | 3.34(1.79–6.25) | 3.64(1.83–7.23) |